Congratulations to Dr. Mo Toure!

On April 22nd, our own Mo Toure successfully completed his PhD thesis, focused on the development of degraders of the CDK9 transcriptional kinase and systems biology approaches to compare degradation versus inhibition of the enzyme. This was a very special defense in that Mo has been both a Harvard undergraduate and an MIT graduate student in the lab. Mo will stick around MIT to explore both medical and commercial translation of the CDK9 degraders and recently successfully acquired a grant with the Johnson Lab in MIT Chemistry to explore degrader-antibody conjugates for CDK9.